NYSE
ABT
Abbott Laboratories
USD 100.7500
0.1800 (+0.1790%)
After Hours: USD 100.160 -0.590 (-0.586%)
Last updated: 24 Jul 2026 7:00:00 AM
DelayedDelayed at least 15 minutes
Last updated: 24 Jul 2026 7:00:00 AM (Singapore Time)
NYSEABT
Abbott Laboratories
DelayedDelayed at least 15 minutes
USD 100.7500
After Hours: USD 100.1600 -0.5900 (-0.5856%)
+0.1790%
+ USD 0.1800
Open
USD 101.2300
Prev. Close
USD 100.5700
Bid
USD 100.1300
Bid Volume
100
Ask
USD 101.6100
Ask Volume
100
Total Volume
9,949,237.554
100.0700
Day's Range
101.9000
81.9700
52 Weeks Range
137.4900
SHOW ALL KEY STATISTICS
ABT Chart
Delayed
Chart data is delayed at least 15 minutes.
Created with Highcharts 9.3.2Chart context menu27. Apr4. May11. May18. May25. May1. Jun8. Jun15. Jun22. Jun29. Jun6. Jul13. Jul20. Jul80859095100105FSM Global
Stock Information
Market Cap
USD 175.49 billion
Share Outstanding
1.74 billion
30 Days Average Volume
13.43 million
Product Currency
USD
Valuations
Earning Per Share
USD 3.730
Price-to-Earnings Ratio (PE)
32.547
Historical Avg. PE Ratio
27.914
Price-to-Book Ratio (PB)
3.365
Price-to-Sales Ratio (PS)
3.769
Price/Earnings-to-Growth Ratio
2.026
Selected Financial Data
Free Cash Flow
USD 7.40 billion
Debt-to-Equity Ratio
0.208
Current Ratio
1.576
Quick Ratio
1.183
Return On Equity (%)
13.07
Return On Assets (%)
7.76
Dividend Info
Hist. Annual Dividend
1.890
Forward Div. Yield (%)
2.510
Pay-out Ratio (%)
78.960
Last Div. Ex Date
15 Jul 2026
Next Div. Ex Date
-
Financial InformationMORE
Created with Highcharts 9.3.2Chart context menuRevenueNet Income20252024202320222021010.00B20.00B30.00B40.00B50.00B
(USD)
2025 YOY Change
2024 YOY Change
2023 YOY Change
2022 YOY Change
2021 YOY Change
Revenue
44.33B
5.67%
41.95B
4.59%
40.11B
-8.12%
43.65B
1.34%
43.08B
24.47%
Operating Income
8.05B
17.99%
6.83B
5.36%
6.48B
-22.53%
8.36B
-0.75%
8.43B
57.27%
Net Income
6.52B
-51.32%
13.40B
134.18%
5.72B
-17.45%
6.93B
-1.95%
7.07B
57.31%
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Sector
Healthcare
Industry Classification
Medical Devices
Product Type
-
Sales
USD 44.33 billion
Market Cap
USD 175.49 billion
Net Income
USD 6.52 billion
Share Outstanding
1.74 billion
Fiscal Year End
31 Dec 2026
52 Weeks Range
USD 81.9700 - USD 137.4900
Employees
115,000
30 Days Average Volume
13.43 million
Payment Method
Included under CashYes
Included under CPFIS OANo
Included under CPFIS SANo
Included under SRSNo
Upcoming Exchange HolidaysMORE
United States (US)
06Sep
Labor Day
25Nov
Thanksgiving Day
26Nov
Day after Thanksgiving (Half-Day Trading)
23Dec
Day before Christmas Day (Half-Day Trading)
24Dec
Christmas Day
Tools
newCalculatorIcon
Stock Calculator
newCalculatorIcon
Stock Returns
newScreenerSelectorIcon
Stock Screener
newCalculatorIcon
Intrinsic Value Calculator
newGainerIcon
Top Gainer Loser